Input interpretation
silver(I) chromate | glycopyrrolate
Chemical names and formulas
| silver(I) chromate | glycopyrrolate formula | Ag_2CrO_4 | C_19H_28NO_3 Hill formula | Ag_2CrO_4 | C_19H_28NO_3 name | silver(I) chromate | glycopyrrolate IUPAC name | disilver dioxido(dioxo)chromium | (1, 1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate alternate names | chromic acid, disilver(1+) salt | chromium silver oxide | disilver(1+) dioxido(dioxo)chromium | disilver dioxido(dioxo)chromium | silver chromate | silver chromate(VI) | (none) mass fractions | Ag (silver) 65% | Cr (chromium) 15.7% | O (oxygen) 19.3% | C (carbon) 71.7% | H (hydrogen) 8.86% | N (nitrogen) 4.4% | O (oxygen) 15.1%
Structure diagrams
| silver(I) chromate | glycopyrrolate vertex count | 7 | 23 edge count | 4 | 26 Schultz index | 64 | 4871 Wiener index | 16 | 1132 Hosoya index | 5 | 52434 Balaban index | 3.024 | 1.711
3D structure
3D structure
Basic properties
| silver(I) chromate | glycopyrrolate molar mass | 331.728 g/mol | 318.44 g/mol phase | liquid (at STP) | solid (at STP) melting point | | 192.5 °C boiling point | 1550 °C | density | 5.625 g/cm^3 |
Units
Hydrophobicity and permeability properties
| glycopyrrolate experimental LogP hydrophobicity | -0.99 predicted LogP hydrophobicity | -1.19 predicted LogS | -5.57
Drug interactions
glycopyrrolate | donepezil | galantamine | haloperidol | rivastigmine (total: 4)